Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Mon, 09.09.2024
Parmantier & Cie. GmbH
Frankfurt am Main, September 09, 2024 - PARMANTIER & CIE. has initiated coverage of CLINUVEL Pharmaceuticals Ltd., Melbourne. CLINUVEL Pharmaceuticals Ltd. is a biopharmaceutical company founded in 1987 and headquartered in Melbourne, Australia. The company is a leader in the development and commercialization of melanocortin-based therapies for [ … ]
Mon, 09.09.2024
CoinShares Digital Securities Limited
9 September 2024
CoinShares Digital Securities Limited
Exchange Traded Products Programme for the issue of
CoinShares Digital Securities
LEI: 549300DR7967WVLR3P83
CoinShares Digital Securities Limited Publishes Half Year Interim Report 2024
Jersey - 9 September 2024 - The board of CoinShares Digital Securities Limited (the "Issuer [ … ]
Mon, 09.09.2024
Secarna Pharmaceuticals GmbH & Co. KG
Secarna Pharmaceuticals will present data at 6th Inflammasome Therapeutics Summit demonstrating the potential of ASOs to target the expression of NLRP3
NLRP3 is a promising target with a well-validated role in various inflammatory disease
Secarna has shown the potential of the company’s ASOs to effectively and specifically suppress NLRP3 and IL- [ … ]
Mon, 09.09.2024
Edison Investment Research Limited
London, UK, 9 September 2024
Edison issues report on Martin Currie Global Portfolio Trust (MNP)
Edison issues report on Martin Currie Global Portfolio Trust (LSE: MNP).
Martin Currie Global Portfolio Trust’s (MNP’s) performance was negatively affected in 2022 by the shift in interest rate expectations as US rates quickly moved up from 0.25 [ … ]
Mon, 09.09.2024
CureVac
CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress
TÜBINGEN, Germany/BOSTON, USA – September 9, 2024 – CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced that the f [ … ]
Mon, 09.09.2024
Edison Investment Research Limited
London, UK, 9 September 2024
Edison issues report on Picton Property Income (PCTN)
Edison issues report on Picton Property Income (LSE: PCTN)
Picton Property Income’s previously agreed sale of a vacated office building in Cardiff, to a purpose-built student accommodation developer, has taken a further step forward. A resolution to grant p [ … ]
Mon, 09.09.2024
Pick a Seat
EQS-Media / 09.09.2024 / 11:17 CET/CEST
Eugène Ionesco's absurdist classic “Bald Diva” reunites iconic duo Haluk Bilginer and Zuhal Olcay, widely acclaimed for their performances in both Turkish and international productions. After selling out performances in Türkiye, the production is coming to five German cities this month.
Berlin — “Bald [ … ]
Mon, 09.09.2024
TRATON SE
TRATON Financial Services Marks a Year of Growth and Global Expansion in Delivering Integrated Financial SolutionsMunich/Södertälje, 09.09.2024 – TRATON Financial Services has completed a dynamic first year, focusing on the rollout of comprehensive and customer-centric financial solutions across key global markets. Over the past year, TRATON Financ [ … ]
Mon, 09.09.2024
Armacell
On 7 September 2024, the process area of Armacell’s Cheonan Armagel Plant suffered a fire followed by an explosion resulting in significant damage to the asset and a stop in all operations. All necessary emergency protocols were activated immediately.
One of our operators was seriously injured. He received immediate medical attention and is reco [ … ]
Mon, 09.09.2024
Edison Investment Research Limited
London, UK, 9 September 2024
Edison issues report on abrdn Asian Income Fund (AAIF)
Edison issues report on abrdn Asian Income Fund (LSE: AAIF).
abrdn Asian Income Fund (AAIF) is managed by abrdn’s well-established Singapore-based Asian equity team, supported by a 40-strong group of analysts based in six locations in the Asia-Pacific regio [ … ]